KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 148 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $442,386 | +27.7% | 113,724 | +11.6% | 0.00% | 0.0% |
Q4 2022 | $346,518 | -19.2% | 101,917 | +29.6% | 0.00% | 0.0% |
Q3 2022 | $429,000 | +410.7% | 78,657 | +321.1% | 0.00% | – |
Q2 2022 | $84,000 | -39.1% | 18,680 | 0.0% | 0.00% | -100.0% |
Q1 2022 | $138,000 | -50.9% | 18,680 | +27.9% | 0.00% | -50.0% |
Q1 2020 | $281,000 | +20.6% | 14,610 | +20.4% | 0.00% | +100.0% |
Q4 2019 | $233,000 | -63.9% | 12,130 | -82.4% | 0.00% | -75.0% |
Q4 2018 | $645,000 | -5.6% | 68,835 | +71.7% | 0.00% | 0.0% |
Q3 2018 | $683,000 | +21.1% | 40,090 | +20.9% | 0.00% | +33.3% |
Q2 2018 | $564,000 | – | 33,170 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |